NPS Pharmaceuticals (NPSP) Scheduled to Post Quarterly Earnings on Tuesday
NPS Pharmaceuticals (NASDAQ:NPSP) is set to issue its quarterly earnings data on Tuesday, February 18th. Investors that are interested in participating in the company’s conference call can do so using this link.
NPS Pharmaceuticals (NASDAQ:NPSP) opened at 37.03 on Monday. NPS Pharmaceuticals has a 1-year low of $7.35 and a 1-year high of $38.74. The stock has a 50-day moving average of $34.90 and a 200-day moving average of $28.62. The company’s market cap is $3.781 billion.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of NPS Pharmaceuticals in a research note on Thursday, February 6th. They now have a $34.00 price target on the stock. On a related note, analysts at TheStreet upgraded shares of NPS Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Monday, January 20th. Finally, analysts at Brean Capital raised their price target on shares of NPS Pharmaceuticals from $36.00 to $41.00 in a research note on Thursday, January 9th. Three analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $37.86.
In other NPS Pharmaceuticals news, Director Georges Gemayel sold 6,188 shares of the company’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $37.70, for a total value of $233,287.60. The transaction was disclosed in a document filed with the SEC, which is available at this link.
NPS Pharmaceuticals, Inc (NASDAQ:NPSP) is a clinical-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.